EPO906 Therapy in Patients With Prostate Cancer

Clinical trial NCT00035113 · COMPLETED

Trial details

NCT number: NCT00035113
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2002-01-01
Primary completion: 2004-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.